|
Volumn 12, Issue 4, 2014, Pages 118-120
|
Obinutuzumab for previously untreated chronic lymphocytic leukemia
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENDAMUSTINE;
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
FLUDARABINE;
IBRUTINIB;
OBINUTUZUMAB;
RITUXIMAB;
ANEMIA;
ARTICLE;
CHILL;
CHRONIC LYMPHATIC LEUKEMIA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG FATALITY;
DRUG SAFETY;
DYSPNEA;
FEBRILE NEUTROPENIA;
FEVER;
FLUSHING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERKALEMIA;
HYPONATREMIA;
HYPOTENSION;
INFECTION;
INFUSION RELATED REACTION;
LEUKOPENIA;
LIVER FAILURE;
LYMPHOCYTOPENIA;
MUSCULOSKELETAL DISEASE;
NAUSEA;
NEOPLASM;
NEUTROPENIA;
PHASE 3 CLINICAL TRIAL (TOPIC);
PNEUMONIA;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SIDE EFFECT;
THROMBOCYTOPENIA;
TOXIC HEPATITIS;
TUMOR LYSIS SYNDROME;
VIRUS INFECTION;
VOMITING;
|
EID: 84988529975
PISSN: 23307749
EISSN: None
Source Type: Journal
DOI: 10.12788/jcso.0032 Document Type: Article |
Times cited : (2)
|
References (3)
|